INDUCTION OF MRP3 (ABCC3) BY OMEPRAZOLE AND ITS UNDERLYING MECHANISMS

被引：0
|
作者：
Pan, Y. Q. [1 ]
Mi, Q. Y. [1 ]
He, B. S. [1 ]
Zhao, S. L. [1 ]
Xie, H. G. [1 ]
机构：
[1] Nanjing Med Univ, Nanjing Hosp, Nanjing, Jiangsu, Peoples R China
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [1] Induction of ABCC3 (MRP3) by pregnane X receptor activators
    Teng, S
    Jekerle, V
    Piquette-Miller, M
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (11) : 1296 - 1299
  • [2] Sinusoidal efflux of bile acids via Mrp3 (ABCC3)
    Akita, H
    Suzuki, H
    Sugiyama, Y
    BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY, 2003, 129 : 104 - 110
  • [3] MRP3/Mrp3(ABCC3/Abcc3) is up-regulated by Tnf α via cholesterol 7 α hydroxylase promoter factor (CPF) and is hepatoprotective in obstructive cholestasis.
    Bohan, A
    Chen, WS
    Denson, LA
    Held, MA
    Boyer, JL
    HEPATOLOGY, 2003, 38 (04) : 168A - 168A
  • [4] Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer
    Partanen, Laura
    Staaf, Johan
    Tanner, Minna
    Tuominen, Vilppu J.
    Borg, Ake
    Isola, Jorma
    GENES CHROMOSOMES & CANCER, 2012, 51 (09): : 832 - 840
  • [5] The molecular mechanism underlying the induction of hepatic MRP3 expression and function by omeprazole
    Pan, Yu-Qin
    Mi, Qiong-Yu
    He, Bang-Shun
    Zhao, Shu-Li
    Tai, Ting
    Xie, Hong-Guang
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (04) : 232 - 244
  • [6] Systematic Screening of Human ABCC3 Polymorphisms and Their Effects on MRP3 Expression and Function
    Sasaki, Tomohiro
    Hirota, Takeshi
    Ryokai, Yuriko
    Kobayashi, Daisuke
    Kimura, Miyuki
    Irie, Shin
    Higuchi, Shun
    Ieiri, Ichiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (04) : 374 - 386
  • [7] Overexpression of MRP3/ABCC3 mRNA in different types of bladder cancer in Egyptian patients
    Rady, M.
    Spahn-Langguth, H.
    Rohde, J.
    Mahran, L.
    Amr, D.
    Ibrahim, S. S.
    Zaghloul, A. S.
    Knuechel-Clarke, R.
    Khaled, H.
    Niess, R.
    Scherl-Mostageer, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 98 - 98
  • [8] Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics
    Ghanem, Carolina I.
    Manautou, Jose E.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (07) : 1185 - 1223
  • [9] Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate
    Vlaming, Maria L. H.
    Pala, Zeliha
    van Esch, Anita
    Wagenaar, Els
    van Tellingen, Olaf
    de Waart, Dirk R.
    Elferink, Ronald P. J. Oude
    van de Wetering, Koen
    Schinkel, Alfred H.
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8152 - 8160
  • [10] Wnt--catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer
    Kobayashi, Minoru
    Funayama, Ryo
    Ohnuma, Shinobu
    Unno, Michiaki
    Nakayama, Keiko
    CANCER SCIENCE, 2016, 107 (12) : 1776 - 1784
12345